1. Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells
    Run-Sheng Guo et al, 2016, Chinese Medical Journal CrossRef
  2. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma
    Tomoya Kanai et al, 2018, Oncology Letters CrossRef
  3. Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
    Peter E. Hall et al, 2021, Expert Opinion on Emerging Drugs CrossRef
  4. Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling
    Yun Han et al, 2020, Cell Cycle CrossRef
  5. microRNA-361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells
    Shuxiang Yang et al, 2016, Molecular Medicine Reports CrossRef
  6. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis
    Xiao-wei Qi et al, 2015, Scientific Reports CrossRef
  7. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
    Qimin Zhou et al, 2019, EBioMedicine CrossRef
  8. Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
    M. Higgins et al, 2017, Breast Cancer Research and Treatment CrossRef
  9. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1
    FeiYan Xie et al, 2017, PLOS ONE CrossRef
  10. Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
    Wen Zhang et al, 2019, Cancer Immunology, Immunotherapy CrossRef
  11. Regulation of breast cancer metastasis signaling by miRNAs
    Belinda J. Petri et al, 2020, Cancer and Metastasis Reviews CrossRef
  12. Correlation of Wilms’ Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer
    Fariba Pishbin et al, 2023, Indian Journal of Clinical Biochemistry CrossRef
  13. WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer
    Richard J. McGregor et al, 2018, British Journal of Cancer CrossRef
  14. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing
    Cheng-Liang Yuan et al, 2019, BMC Cancer CrossRef
  15. Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
    Wei Xin et al, 2021, Pathology and Oncology Research CrossRef
  16. Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer
    Fariba Pishbin et al, 2021, Personalized Medicine CrossRef
  17. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Weiqiang Zhou et al, 2016, Scientific Reports CrossRef
  18. BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma
    Xing Chen et al, 2022, Journal of Translational Medicine CrossRef
  19. Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms
    Hind Ben Haj Othmen et al, 2024, Molecular Biology Reports CrossRef
  20. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
    Julian Rauscher et al, 2014, Journal of Clinical Pathology CrossRef
  21. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple‐negative tumours
    Elena Provenzano et al, 2016, Histopathology CrossRef
  22. The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells
    Rassanee Bissanum et al, 2017, Biochemical and Biophysical Research Communications CrossRef